NeuroPace (NPCE) EBITDA Margin (2020 - 2026)
NeuroPace's EBITDA Margin was -8.26% in Q3 2026, up 8.25 percentage points from -16.51% a year earlier and up 13.52 percentage points from the prior quarter.
Powered by 
Analysis
NeuroPace (NPCE) EBITDA Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, NeuroPace's EBITDA Margin was -8.97% through Sep 30, 2026, up 14.67 percentage points year-over-year; for FY2025, it was -15.87%, up 10.71 percentage points from FY2024.
- EBITDA Margin has now increased for three consecutive years, with a five-year change of +6.61 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was -26.58% in FY2024 (+14.22 pp), -40.80% in FY2023 (+47.59 pp), -88.39% in FY2022 (-37.11 pp) and -51.28% in FY2021 (-28.80 pp).
- Quarterly EBITDA Margin has moved between -106.01% (Q2 2022) and 7.05% (Q4 2025) over five years.
- Compared with a year earlier, EBITDA Margin was higher in six of the last eight quarters, with an average year-over-year change of +8.94 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q2 2023 (a gain of 59.46 percentage points); the worst was Q2 2022 (a drop of 70.92 percentage points).
- Per Business Quant data, NPCE's EBITDA Margin in the three quarters before Q3 2026 was -21.79% (Q2 2026), -24.65% (Q1 2026) and 7.05% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 259.44 Bn | 236.08 Bn | 5.13 Bn | 25.44% |
| 2 | Abbott Laboratories | 187.98 Bn | 162.45 Bn | 7.39 Bn | 20.09% |
| 3 | Danaher | 163.91 Bn | 143.58 Bn | 3.84 Bn | 30.00% |
| 4 | Intuitive Surgical | 153.75 Bn | 134.17 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 131.67 Bn | 97.80 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 117.84 Bn | 104.03 Bn | 4.25 Bn | - |
| 7 | Boston Scientific | 64.27 Bn | 59.95 Bn | 3.43 Bn | 23.14% |
| 8 | Edwards Lifesciences | 61.69 Bn | 45.00 Bn | 1.35 Bn | 20.05% |
| 9 | Medline | 51.94 Bn | 49.07 Bn | 1.93 Bn | 9.79% |
| 10 | NeuroPace | 260.31 Mn | 44.34 Mn | 19.47 Mn | -8.26% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -8.26% |
| Jun 30, 2026 | -21.79% |
| Mar 31, 2026 | -24.65% |
| Dec 31, 2025 | -6.27% |
| Sep 30, 2025 | -8.88% |
| Jun 30, 2025 | -41.20% |
| Mar 31, 2025 | -22.42% |
| Dec 31, 2024 | -16.76% |
| Sep 30, 2024 | -19.45% |
| Jun 30, 2024 | -31.55% |
| Mar 31, 2024 | -40.95% |
| Dec 31, 2023 | -27.24% |
| Sep 30, 2023 | -35.16% |
| Jun 30, 2023 | -46.55% |
| Mar 31, 2023 | -56.71% |
| Dec 31, 2022 | -75.89% |
| Sep 30, 2022 | -89.94% |
| Jun 30, 2022 | -106.01% |
| Mar 31, 2022 | -84.36% |
| Dec 31, 2021 | -80.61% |
API Access
NeuroPace EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NPCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NPCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NPCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();